PSTV Message Board Post 9967918 | PLUS THERAPEUTICS Inc.
home / stock / pstv / pstv message board
SkyHill
(investorshub)
Posted on: Sep/12/2022 11:29:25
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169923276
NEWS -- Plus Therapeutics Presents Positive Phase 1
News, Short Squeeze, Breakout and More Instantly...
-
AUSTIN, Texas, July 02, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS...
-
Greg Fuller, M.D., Ph.D., former Professor of Pathology (Neuro-Pathology) & Neuro-Radiology at The University of Texas MD Anderson Cancer Center joins Plus as Vice President of Medical Affairs and Medical Director Plus receives notice of an additional $3.3 million CPRIT advance paym...
- PSTV - Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Announced private placement of up to $19.25M with healthcare funds and insiders Received $3M award recommendation from the Department of Defense to support Plus’ clinical brain cancer program Acquired synergistic leptomeningeal metastases diagnostic portfolio and announce...